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Abstract
Background: Reproductive health disparities may be partly explained by the cumulative effects 
of chronic stress experienced by socially disadvantaged groups. Although, telomere length (TL) 
and allostatic load score have each been used as biological markers of stress, the relationship 
between these two measures is unknown.
Methods: We investigated the association between leucocyte TL and allostatic load score in 1503 
non-pregnant women (20–44 years) participating in the National Health and Nutrition 
Examination Survey, 1999–2002. We constructed six different allostatic load scores using either 
quartile- or clinical-based cut-points for 14 biomarkers based on previously published methods. 
We estimated associations between TL and allostatic load scores and component biomarkers using 
linear regression, also assessing interactions by race/ethnicity.
Results: After adjustment for age, longer TL was associated with higher HDL cholesterol and 
lower C-reactive protein and creatinine clearance; TL was not associated with the other component 
biomarkers. Shorter TL was associated with higher allostatic load scores for the two clinical cut-
point-based scores after adjustment for age, but not the four scores based on quartile cut-points. 
Significant interactions by race/ethnicity were observed for TL and HbA1c and triglycerides, but 
not for other component biomarkers or allostatic load scores.
Conclusions: Although TL and allostatic load score are both considered measures of cumulative 
stress, most component biomarkers and scores using quartile-based cut-points were not associated 
with TL. In reproductive-aged women, allostatic load scores using clinical-based cut-points were 
more strongly associated with TL compared with quartile-based scores.
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In the US, non-Hispanic black women experience higher rates of preterm birth and low 
birthweight deliveries compared with non-Hispanic white women.1 Premature ‘weathering’ 
refers to the hypothesis that cumulative, chronic stress resulting from socio-economic 
adversity can adversely affect physical health2; this construct has been hypothesised to 
contribute to the long-standing racial disparities in reproductive outcomes observed in the 
US.2,3 Telomere length4–8 and allostatic load scores9–13 have each been used to measure 
premature weathering, but the relationship between these two measures has not yet been 
examined.
Telomeres are the protective DNA-protein complexes capping the end of chromosomes and 
naturally shorten with each cellular division, leading to genetic instability and eventually 
resulting in cellular senescence. Shorter telomeres are associated with both chronological 
ageing and increased mortality and morbidity independent of chronological age.14 To date, 
telomere length (TL) has been related to a variety of factors including race, education, 
socioeconomic status, smoking, physical activity, diet, and stress – supporting the hypothesis 
that telomeres shorten in response to cumulative, chronic stress.4–6,14–17 Recently, TL has 
also been shown to be associated with reproductive outcomes.18–20
Allostasis refers to an organism’s dynamic physiologic response to the demands of a 
changing environment. ‘Allostatic load’ represents ‘the wear and tear the body experiences 
when repeated allostatic responses are activated during stressful situations;’9,11 like TL, 
allostatic load is often considered a biological effect of cumulative, chronic stress and is 
related to subsequent adverse health outcomes.9–13 Allostatic load has been operationalised 
using a variety of score-based approaches with no gold standard.9 The association between 
allostatic load score and various demographic factors and clinical conditions has been 
evaluated using the National Health and Nutrition Examination Study (NHANES) data in 
over 25 publications (Table S1).21–26
We examined the association between leucocyte TL and allostatic load scores in a national 
sample of non-pregnant reproductive-aged women using data from NHANES. We selected 
reproductive-aged women to represent the source population from which pregnancies, and 
therefore disparities in pregnancy outcomes, arise. Allostatic load was operationalised 
according to several previously used methods. Published analyses of NHANES data have 
shown higher allostatic load scores,27 but longer TL,16 in non-Hispanic blacks compared 
with non-Hispanic whites, which is an unexpected finding given allostatic load score and TL 
purport to measure the same phenomenon. One possible explanation for this might be an 
inconsistent relationship between allostatic load score and TL by race/ethnicity, which we 
investigated as part of our analysis.
Methods
Study population
NHANES is a cross-sectional, complex, multistage probability sampling survey conducted 
by the Centers for Disease Control and Prevention’s (CDC) National Center for Health 
Statistics (NCHS) designed to assess the health and nutritional status of non-institutionalised 
civilians living in the US.28 During 1999–2002, 3569 women aged 20–49 were eligible for 
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the survey, 2935 (82%) were interviewed and 2771 (78%) participated in the examination 
component.29 The NCHS Ethics Review Board at the CDC approved the NHANES data 
collection and no specific additional review was required for this analysis, which used data 
from public-use files.
Telomere length
Persons aged 20 and over at the time of the interview were asked to provide whole blood for 
DNA analysis. At the Division of Health Statistics Laboratory, CDC, DNA was extracted 
from specimens and stored at −80°C; purified DNA samples were then coded and shipped to 
an outside laboratory (Dr. Elizabeth Blackburn at the University of California, San 
Francisco) for analysis as part of a surplus specimen project.16 The leucocyte telomere/
standard (T/S) ratio was measured for each sample three times (in duplicate) using the 
quantitative polymerase chain reaction (PCR) method, resulting in six measurements which 
were used to calculate the mean and standard deviation of the T/S ratio for each participant.
15
 The T/S ratio (also referred to as ‘relative telomere length’) is directly proportional to 
mean TL and will be referred to as ‘telomere length’ throughout this manuscript for ease of 
understanding.30 The mean T/S ratio can be converted to number of base pairs using the 
following formula: 3274 + 2413 * (T/S ratio).16
Allostatic load
In addition to whole blood collection, the NHANES examination component consisted of 
physical measurements and serum and urine collection. Laboratory methods for biospecimen 
analysis have previously been described.31,32 Approximately half of the participants were 
instructed to fast overnight before their examination appointment in order to ascertain 
fasting blood glucose and lipid levels.
Allostatic load has been operationalised in many different ways. Following previously 
published algorithms that have been applied to NHANES 1999–2002 data among 
reproductive-aged adults, we operationalised allostatic load scores in six different ways to 
examine whether associations with TL might differ according to the method of defining 
allostatic load. These six different scoring methods used either quartile-based22,24,26,27,33,34 
or clinical-based25,35 cutpoints to categorise individuals as low risk (score of 0) or high risk 
(score of 1) for each of the component biomarkers included its score. These component 
scores were then summed across the included biomarkers to generate a total allostatic load 
score. All six methods of defining allostatic load scores were therefore count-based, though 
each was constructed using a different set of biomarkers and/or cut-points (see Table S2 for 
biomarkers and cut-points used in each allostatic load score). The total number of 
biomarkers measured across all of the previously published scoring methods was 14, though 
each score summed over a subset of 9 or 10 biomarkers.
High-risk quartile cut-points were determined from the weighted distribution of each of the 
following biomarkers in our analytic sample: C-reactive protein (CRP), mg/dL; serum 
albumin, g/dL; body mass index (BMI), kg/m2; glycohaemoglobin (HbA1c), %; systolic 
blood pressure, mm Hg; diastolic blood pressure, mmHg; high-density lipoprotein (HDL) 
cholesterol, mg/dL; total cholesterol, mg/dL; triglyceride, mg/dL; homocysteine, μmol/L; 
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pulse, beats/min; serum creatinine, mg/dL; urine creatinine, mg/dL and creatinine clearance, 
mL/min (estimated using the Cockcroft-Gault equation).36 For the following biomarkers, 
high-risk groups were also determined based on clinically significant or empirically defined 
cut-points:25,35 CRP, serum albumin, BMI, HbA1c, systolic blood pressure, diastolic blood 
pressure, HDL, total cholesterol, and pulse.
Participants reporting medication use for diabetes, hypertension, or high cholesterol, were 
assigned to the high-risk group for HbA1c; systolic and diastolic blood pressure; and total 
cholesterol, respectively. Ten-point allostatic load scores were calculated by summing 
membership in high-risk groups with each biomarker equally weighted (possible range 0–
10); prior to summation, 9-point scores were rescaled to 10-point scores for comparison 
purposes.25,26,35 Allostatic load scores were only calculated for women with non-missing 
values for all component biomarkers for each score.
Participant characteristics
Participant characteristics examined included age, Hispanic origin and race, marital status, 
smoking history, educational attainment, and household income as a percentage of poverty 
level. Pregnancy status was ascertained by combining information from the interview with 
results from a spot urine pregnancy test.
Statistical analysis
We limited our analysis to women 20–44 years old who provided DNA specimens for TL 
measurement and who completed the examination component of the survey. Pregnant 
women were excluded from our analysis because many allostatic load biomarkers are 
affected by pregnancy.24 For the comparisons of TL and allostatic load component 
biomarkers, women missing individual biomarkers were excluded from that biomarker’s 
analysis but retained in other bio-marker analyses if information was available. All analyses 
accounted for the multistage, complex sampling design and used either the mobile 
examination centre weights or the fasting morning subsample weights (for analyses 
concerning triglycerides).37 No adjustment was made for fasting, as recent evidence 
suggests fasting time shows little association with total cholesterol and HDL levels.38
Telomere length was log-transformed. We used unadjusted linear regression to calculate 
mean TL by characteristics of study participants and for component biomarkers (low-risk 
quartile, 25th to 75th percentile, high-risk quartile). We performed significance testing of the 
difference in mean TL between the highest and lowest risk quartiles for each component bio-
marker. In addition, differences in mean TL were estimated per 1 or 10 unit increase 
(depending on the range of biomarker values) in each allostatic load bio-marker using linear 
regression. Similarly, we estimated the difference in TL per 1 unit increase in allostatic load 
score. All regression models were further adjusted for age, which is positively associated 
with higher allostatic load scores and shorter TL, by including continuous age (in years) as a 
covariate. Linear regression coefficients were exponentiated to calculate the percent change 
in TL on the original scale for ease of interpretation. All P-values for general linear F tests 
were determined using the Satterth-waite adjusted F-test.39
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To assess differences in the relationship between TL and allostatic load biomarkers and 
scores by race/ethnicity, interaction terms for race/ethnicity (Mexican American, non-
Hispanic white, non-Hispanic black) and allostatic load were added to regression models 
adjusted for age and race/ethnicity. We used the general linear Satterthwaite adjusted F-test 
to determine the significance of adding the interaction term to the model. To evaluate the 
effect of assigning high-risk group status based on medication use, we reran the models of 
TL and allostatic load scores after excluding women who had been assigned to high-risk 
groups based solely on their medication use. We also used multiple imputation to assign 
values to individual missing biomarkers so that allostatic load scores could be constructed 
for all women in our analysis; imputations used chained equations and predictive mean 
matching with demographics and non-missing biomarkers as predictor variables. Results 
using allostatic load scores based on these imputations were compared with the main results 
in a sensitivity analysis.
All analyses were conducted with SAS 9.3 (SAS Institute, Cary, NC, USA) and SAS-
callable SUDAAN 11.0 (RTI International, Research Triangle Park, NC, USA).
Results
Study population
There were 2386 women between the ages of 20 and 44 years at the time of the interview 
who participated in NHANES 1999–2002 and took part in the examination component. Of 
those, 1954 (82%) had leucocyte TL measured, 451 of whom were excluded from our 
analysis (444 were pregnant and 7 were 45 years old at time of the exam), leaving 1503 in 
our analytical sample. Among those eligible for TL measurement, non-Hispanic white 
women were more likely than non-Hispanic black women to provide specimens (Table S3). 
No significant differences in provision of specimens for TL measurement were observed by 
age, marital status, smoking, education, and poverty level.
Telomere length
Geometric mean TL (reported as T/S ratio), was 1.12 (95% confidence interval (CI): 1.08, 
1.16), which was equivalent to 6045 base pairs (95% CI 5951, 6139). After adjustment for 
age, mean TL varied by race/ethnicity and marital status (Table 1). Non-Hispanic black 
women had longer telomeres compared with non-Hispanic white and Mexican American 
women. Never married women had longer telomeres compared with married, living with 
partner, or no longer married (separated, divorced or widowed) women.
Allostatic load biomarkers
There were 37, 72, and 13 participants (not mutually exclusive) reporting medication use for 
diabetes, hypertension, or high cholesterol, respectively, who were subsequently assigned to 
the high-risk group for the corresponding biomarkers. In most of these instances (75/122), 
the women were already categorised in the high-risk group for the respective biomarker.
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Telomere length and allostatic load biomarkers
Mean TL was shorter in the high-risk quartile compared with the low-risk quartile for CRP, 
BMI, and diastolic blood pressure (Table 2). After adjustment for age, mean TL was shorter 
in the high-risk quartiles for CRP and HDL. For the remaining biomarkers, there was no 
significant difference in TL between the high- and low-risk quartiles.
In models with component biomarkers as continuous linear variables, increases in BMI, 
HbA1c, systolic blood pressure, diastolic blood pressure, and total cholesterol were 
associated with shorter TL and an increase in HDL cholesterol was associated with longer 
TL (Table 3). However, all associations were null after adjustment for age except for HDL 
cholesterol, which showed a 1.2% longer TL (β (95% CI: 0.004, 0.020)) per 10 mg/dL 
increase and creatinine clearance, which gained significance showing a 0.4% shorter 
telomere length (β (95% CI: −0.008, 0.000)) per 10 mL/min increase. Interactions with race/
ethnicity were significant for two biomarkers (Figure 1): HbA1c, which showed a negative 
relationship with TL for non-Hispanic whites compared with a flat slope for Mexican 
Americans and non-Hispanic blacks; and triglycerides, which showed a negative relationship 
with TL for non-Hispanic blacks compared with nearly flat slopes for non-Hispanic whites 
and Mexican Americans. For the remaining 12 biomarkers, differences in the relationship 
between TL and biomarker level were not observed among race/ethnicity groups.
Allostatic load scores
Clinical cut-points were generally more stringent than quartile-based cut-points, which 
resulted in lower average allostatic load scores for clinical-based scoring methods (scoring 
method 2: mean = 1.34 (95% CI:1.25, 1.43); scoring method 4: 1.74 (95% CI: 1.64, 1.85)) 
compared with quartile-based scores (scoring method 1: 2.52 (95% CI: 2.34, 2.70); scoring 
method 3: 2.55 (95% CI: 2.41, 2.68); scoring method 5: 2.54 (95% CI:2.42, 2.65); scoring 
method 6: 2.31 (95% CI: 2.20, 2.42)). The standard error was largest for scoring method 1, 
in part because this allostatic load score included triglycerides which were only available 
from the fasting morning subsample and reduced the number of observations by 
approximately half. The allostatic load scores based on clinical cut-points shared the same 
nine biomarkers (but not the same cut-points), which differed from the quartile-based cut-
point scores by not including measures of creatinine, triglycerides, or homocysteine (Table 
S2). Mean allostatic load scores were higher for non-Hispanic black compared with white 
women for all scoring methods (range of difference: 0.58–0.89); and Mexican Americans 
had a lower mean allostatic load score compared to non-Hispanic white women for scoring 
method 5 (difference = −0.40 (95% CI: −0.63, −0.16)); no other differences in allostatic load 
score by race/ethnicity were observed.
Telomere length and allostatic load scores
With the exception of scoring method 1, higher allostatic load scores were significantly 
associated with shorter TL in the unadjusted analysis (Figure S1). After adjustment for age, 
only allostatic load scores based on clinical-based cut-points remained associated with TL 
(−1.3% for scoring method 2 and −1.2%, for scoring method 4) (Figure 2). Differences by 
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race/ethnicity for the relationships between TL and allostatic load score were not significant 
(all interaction term P-values >0.26).
After the exclusion of women with at least one high-risk grouping determined solely by 
medication use, the associations between TL and allostatic load became stronger for all 
allostatic load scores (all β were farther from zero). This exclusion resulted in three of the 
four quartile-based allostatic load scores (scoring methods 3, 5, 6) becoming significantly 
associated with shorter TL after adjustment for age. The estimated relationships between TL 
and allostatic load scores using imputed biomarkers were 0.1–0.2 percentage points stronger 
and estimated with greater precision compared to the main analysis (Figure S2).
Comment
Among a nationally representative sample of non-pregnant reproductive-aged women aged 
20–44, leucocyte TL was not consistently associated with allostatic load scores that used 
quartile-based cut-points. However, allostatic load scores based on clinical-cut points, which 
often were more stringent than quartile-based cut-points, were inversely associated with TL 
after adjusting for age. For these allostatic load scores, we found that every 1 point increase 
was associated with an approximately 1.5% shorter TL. In terms of component biomarkers, 
longer TL was associated with higher levels of HDL cholesterol, lower CRP, and, 
unexpectedly, lower creatinine clearance. For the most part, the associations between TL and 
allostatic biomarker components and scores did not differ by race/ethnicity. Our findings 
suggest that epidemiologic analyses concerning mechanisms of reproductive health 
disparities should consider how allostatic load scores are operationalised and that scores 
using clinical cut-points were more strongly associated with TL in our study population of 
reproductive-aged women.
While no previous study has assessed the relationship between TL and allostatic load score, 
studies have described associations between TL and total cholesterol, HDL cholesterol, LDL 
cholesterol, triglycerides, and systolic and diastolic blood pressure.14 Our study’s finding of 
longer TL associated with higher HDL cholesterol after adjustment for age is in general 
agreement with one previous study,40 although other studies have found null or negative 
associations.14 Our finding of shorter TL associated with higher CRP is in-line with at least 
one previous study;41 another study found no association in women.42
Several mechanisms have been proposed to explain how allostatic load and telomere 
shortening may be related. Epel suggested higher allostatic load leads to shorter telomeres 
via increased abdominal adiposity, inflammation, and oxidative stress.8 Geronimus proposed 
that responses to repeated or prolonged stressors can increase allostatic load which, in turn, 
shortens TL via accelerated biological ageing.43 Telomere length has also been 
recommended as bio-marker for inclusion in allostatic load score.3 Our findings of 
inconsistent relationships between allo-static load biomarkers and scores and TL suggests 
further investigation of the relationship between these measures may be necessary.
Consistent with previous studies that have found allostatic load to be higher in black 
compared with white women24,27,44, but shorter telomeres in whites as compared to blacks,
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14
 we observed longer mean TL and higher mean allostatic load scores in black compared 
with white women. However, we found no statistically significant interactions by race/
ethnicity. These patterns were therefore seemingly not the result of differing relationships 
between TL and allostatic load scores across race groups, but instead show differences by 
race in the distributions of these measures of cumulative, chronic stress. While differential 
rates of age-related telomere shortening by race could also contribute to these patterns, 
especially as new evidence suggests TL might be longer in blacks compared to whites at 
birth,45 this cannot be explored using cross-sectional data.
This analysis has a few limitations. We compared TL with a limited set of previously used 
allostatic load-scoring methods which were originally constructed based on the biomarkers 
available in NHANES and included markers of secondary effects of primary stress 
mediators.27 Primary mediators include cortisol, epinephrine, and other substances the body 
releases when stressed, but were not available in NHANES. Future research may consider 
whether an allostatic load score comprised of primary mediators of stress might have a 
stronger association with TL. Telomere length was measured using PCR, which is a method 
that is amenable to epidemiologic studies because it is faster and uses a smaller quantity of 
blood compared with Southern Blot. However, PCR methods may be inferior to Southern 
Blot because of high within person heterogeneity and no agreed-upon reference gene 
standard.14 Non-Hispanic white women were more likely to provide DNA samples 
compared with non-Hispanic black women, which, although ostensibly corrected using non-
response reweighting techniques, may have resulted in residual selection bias. However, we 
have no reason to believe that the relationship between telomeres and allostatic load was 
different for women who did and did not provide DNA samples. Finally, we evaluated the 
relationship between TL and allostatic load in non-pregnant reproductive-aged women; 
future research could explore the relationship between these measures of cumulative stress 
and adverse pregnancy outcomes. Studies could also consider the relationship between these 
two measures in other age groups and in men.
One strength of our study was that TL and biomarkers were from a large, nationally 
representative sample of US women. Most prior studies examining TL were based on 
smaller, less diverse samples. Additionally, our analysis was able to replicate the 
construction of allostatic load scores using several different scoring methods with the same 
data source; however, our analyses were not identical to the previous studies due to 
differences in the age of our study population and global analytic decisions about exclusion 
criteria and how missing biomarker data were handled. We also performed separate 
sensitivity analyses excluding women assigned to a high-risk biomarker group-based solely 
on medication use and multiply imputing missing biomarker values, which each resulted in 
slightly stronger associations between TL and allostatic load score. Though our original 
approach regarding medication use is generally preferred because medication use reflects 
previous exposure to high-risk levels of biomarkers, at least one study explicitly ignored 
medication use when determining high-risk status.22 The results of our multiple imputation 
sensitivity analysis suggest that if all biomarker data were available our estimates of 
association would be 0.1–0.2 percentage points stronger per 1 unit increase in allostatic load 
score.
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In conclusion, although TL and allostatic load score are both considered measures of 
cumulative, chronic stress, associations between these two measures were inconsistent in our 
study population of reproductive-aged women. While TL was not associated with most 
individual component biomarkers of the allostatic load scores we examined, some 
combination of biomarkers with clinically defined high-risk cut-points might be. Telomere 
length and allostatic load scores might also be measurements of different aspects of 
cumulative stress exposure. Epidemiologic analyses concerning mechanisms of reproductive 
health disparities should consider how best to opera-tionalised premature weathering given 
the variety of biological data available.
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Figure 1. 
Interactions in the linear relationship with mean log telomere length by race for 
glycohaemoglobin (a) and triglycerides (b). P-value for slopes from Wald test using linear 
regression model adjusted for age.
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Figure 2. 
Percent difference in mean telomere length per 1 unit increase in allostatic load score 
adjusted for age among non-pregnant reproductive-aged women (20–44 years old) in 
NHANES, 1999–2002. NHANES, National Health and Nutrition Examination Survey. 
Allostatic load scores were constructed using biomarkers and cut-point methods previously 
implemented. See text, Table S2 and reference list for details. P-value for slopes from Wald 
test using linear regression model adjusted for age. Of the 1503 observations with telomere 
data, the following biomarkers and number of observations were used for allostatic load 
score construction for each method: scoring method 1 – SBP, DBP, BMI, A1C, ALB, CRU, 
TRI, CRP, HOM, TC (n = 627); scoring method 2 – SBP, DBP, BMI, A1C, ALB, CRP, TC, 
HDL, PLS (n = 1417); scoring method 3 – SBP, DBP, BMI, A1C, ALB, CRP, HOM, TC, 
HDL, PLS (n = 1416); scoring method 4 – SBP, DBP, BMI, A1C, ALB, CRP, TC, HDL, 
PLS (n = 1417); scoring method 5 – SBP, DBP, A1C, ALB, CRS, CRP, HOM, TC, HDL, 
PLS (n = 1428); and scoring method 6 – SBP, DBP, BMI, A1C, ALB, CRC, CRP, TC, HDL 
(n = 1422). SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass 
index; A1C, glycosylated haemoglobin; ALB, serum albumin; TRI, triglycerides; CRP, C-
reactive protein; HOM, homocysteine; TC, total cholesterol; HDL, high-density lipoprotein 
cholesterol; PLS, pulse; CRU, urine creatinine; CRS, serum creatinine; CRC, creatinine 
clearance.
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